Ignite Creation Date:
2025-12-24 @ 4:45 PM
Ignite Modification Date:
2025-12-24 @ 4:45 PM
Study NCT ID:
NCT03960450
Status:
COMPLETED
Last Update Posted:
2020-11-18
First Post:
2019-05-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Topical Administration of BOS-475 in Healthy Subjects and Patients With Psoriasis
Sponsor:
Boston Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-23
Start Date Type:
ACTUAL
Primary Completion Date:
2020-01-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01-28
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-21
First Submit QC Date:
None
Study First Post Date:
2019-05-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-17
Last Update Post Date:
2020-11-18
Last Update Post Date Type:
ACTUAL